Kimberly-Clark KMB underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 2 | 8 | 2 | 1 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 6 | 2 | 1 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $140.47, along with a high estimate of $165.00 and a low estimate of $115.00. Surpassing the previous average price target of $128.86, the current average has increased by 9.01%.
Breaking Down Analyst Ratings: A Detailed Examination
The analysis of recent analyst actions sheds light on the perception of Kimberly-Clark by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Chris Carey | Wells Fargo | Raises | Equal-Weight | $138.00 | $136.00 |
| Kevin Grundy | Exane BNP Paribas | Announces | Neutral | $146.00 | - |
| Nik Modi | RBC Capital | Maintains | Outperform | $165.00 | $165.00 |
| Anna Lizzul | B of A Securities | Raises | Buy | $160.00 | $115.00 |
| Nik Modi | RBC Capital | Raises | Outperform | $165.00 | $126.00 |
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $136.00 | $132.00 |
| Filippo Falorni | Citigroup | Raises | Sell | $125.00 | $111.00 |
| Anna Lizzul | B of A Securities | Raises | Underperform | $115.00 | $110.00 |
| Nik Modi | RBC Capital | Raises | Sector Perform | $126.00 | $123.00 |
| Alejandro Zamacona | HSBC | Raises | Hold | $150.00 | $146.00 |
| Peter Grom | UBS | Raises | Neutral | $138.00 | $135.00 |
| Andrea Teixeira | JP Morgan | Raises | Underweight | $123.00 | $115.00 |
| Chris Carey | Wells Fargo | Raises | Equal-Weight | $136.00 | $131.00 |
| Jason English | Goldman Sachs | Raises | Buy | $152.00 | $135.00 |
| Lauren Lieberman | Barclays | Raises | Equal-Weight | $132.00 | $124.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Kimberly-Clark. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Kimberly-Clark compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Kimberly-Clark's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
For valuable insights into Kimberly-Clark's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Kimberly-Clark analyst ratings.
Discovering Kimberly-Clark: A Closer Look
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Breaking Down Kimberly-Clark's Financial Performance
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Kimberly-Clark's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately -0.89%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 12.57%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Kimberly-Clark's ROE stands out, surpassing industry averages. With an impressive ROE of 66.05%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Kimberly-Clark's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.76% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Kimberly-Clark's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 7.63.
How Are Analyst Ratings Determined?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
